Most Popular Stories
Events
- ABA Wealth Management and Trust Conference
March 14 - 16, 2012 — Westin Kierland, Scottsdale, AZ - 8th Pharma/Bio Accounting and Reporting Congress
March 19 – 21, 2012 - NFC Ticketing Europe 2012
March 20-21 — London - ABA Risk Management Forum
May 2 - 4, 2012 — Loews New Orleans, New Orleans, LA
Sponsored Links
FEATURES >> Highest Paid Bank CEOs | Top 10 Financial Failures of 2011
TOPICS >> MF Global | Occupy Wall Street | Dodd-Frank | Top Banks: GS C BAC JPM WFC MS
Latest News
Free Newsletter
FierceFinance is the financial services daily monitor, with news covering the banking industry, asset management, capital markets and SEC regulations. Sign up today!
Paul Tudor Jones fares well in quant trading
Paul Tudor Jones is not known as a quant. But he entered the field last year and seems to have hit a home run, reports the New York Post. His Tensor fund, run by Steve Evans, has racked up a 19 percent gain, year-to-date. That has put the fund at the top of the class. Goldman Sachs Asset Management's Global Equities Opportunities has slipped a bit, eking out a 1 percent gain. James Simons is also off his game a bit. Renaissance Institutional Equities Fund is down about 4 percent this year. It is notoriously hard for any hedge fund to string together multiple years of above average gains. So we'll have to reserve final judgment. But it does appear that Evans may be the man Jones is looking for. Trading star James Polatta will leave Jones at the end of the year.
For more:
- here's the New York Post article
Related Article:
Paul Tudor Jones 20 years after the crash
Related Stories
- James Simons to step down
- Will Goldman Sachs make a massive bet against Western economies?
- Renaissance Technologies faring well this year
- Hedge fund honchos wonder if it's time to quit
- Druckenmiller to retire from hedge fund industry
- Big hedge fund vs. Goldman Sachs
- James Simons' RIEF problems
- James Simons on the defensive?
- Merrill, Goldman had inkling on Madoff
- A winning hedge fund for Jim Simons
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| EditorsTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |



